Published in Acta Neuropathol on April 24, 2011
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study. Lancet Neurol (2014) 2.66
Biomarker modeling of Alzheimer's disease. Neuron (2013) 2.51
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain (2013) 1.64
Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study. Lancet Neurol (2015) 1.55
Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol (2013) 1.41
Comparative Incidence of Conformational, Neurodegenerative Disorders. PLoS One (2015) 1.40
Brain changes in older adults at very low risk for Alzheimer's disease. J Neurosci (2013) 1.31
What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus. Prog Neurobiol (2014) 1.29
CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease. Acta Neuropathol (2013) 1.15
Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain (2013) 1.13
Suspected non-Alzheimer disease pathophysiology - concept and controversy. Nat Rev Neurol (2016) 1.10
ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol (2014) 1.07
Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J Gerontol A Biol Sci Med Sci (2012) 1.06
Multiple pathologies are common and related to dementia in the oldest-old: The 90+ Study. Neurology (2015) 1.05
Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. J Alzheimers Dis (2014) 1.00
BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease. PLoS One (2013) 0.98
The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab (2016) 0.98
Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia. J Alzheimers Dis (2013) 0.97
Alzheimer's disease: a clinical practice-oriented review. Front Neurol (2012) 0.95
Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. J Alzheimers Dis (2015) 0.93
Hypertension, brain damage and cognitive decline. Curr Hypertens Rep (2013) 0.91
Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease. Front Physiol (2013) 0.88
Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old. Brain (2014) 0.88
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab (2016) 0.88
Neuropathological approaches to cerebral aging and neuroplasticity. Dialogues Clin Neurosci (2013) 0.87
Dementia in the oldest old. Nat Rev Neurol (2013) 0.86
Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals. BMC Med (2012) 0.85
Selective alterations of neurons and circuits related to early memory loss in Alzheimer's disease. Front Neuroanat (2014) 0.85
Chronic depression as a model disease for cerebral aging. Dialogues Clin Neurosci (2013) 0.84
Brain pathologies in extreme old age. Neurobiol Aging (2015) 0.84
Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology. J Neuropathol Exp Neurol (2015) 0.83
The association of diabetes and dementia and possible implications for nondiabetic populations. Expert Rev Neurother (2011) 0.82
Obesity and diabetes cause cognitive dysfunction in the absence of accelerated β-amyloid deposition in a novel murine model of mixed or vascular dementia. Acta Neuropathol Commun (2014) 0.82
T Cell Recruitment in the Brain during Normal Aging. Front Cell Neurosci (2012) 0.81
The Statistical Modeling of Aging and Risk of Transition Project: Data Collection and Harmonization Across 11 Longitudinal Cohort Studies of Aging, Cognition, and Dementia. Obs Stud (2015) 0.80
Association between risk factors for vascular dementia and adiponectin. Biomed Res Int (2014) 0.78
Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment. Neurobiol Aging (2015) 0.78
Alzheimer disease: AD pathology--emerging subtypes or age-of-onset spectrum? Nat Rev Neurol (2011) 0.77
The role of cerebrovascular disease when there is concomitant Alzheimer disease. Biochim Biophys Acta (2015) 0.77
Quantitative neuropathological assessment to investigate cerebral multi-morbidity. Alzheimers Res Ther (2014) 0.77
Serum protein mediators of dementia and aging proper. Aging (Albany NY) (2016) 0.76
Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo. Biochim Biophys Acta (2015) 0.76
Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy. J Mol Psychiatry (2016) 0.76
Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors. Alzheimers Dement (Amst) (2016) 0.75
Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2. Neurobiol Aging (2017) 0.75
Cerebrovascular pathology and Alzheimer's disease. Lancet Neurol (2016) 0.75
Dementia in the oldest old. Continuum (Minneap Minn) (2013) 0.75
An expedient synthesis, acetylcholinesterase inhibitory activity, and molecular modeling study of highly functionalized hexahydro-1,6-naphthyridines. Biomed Res Int (2015) 0.75
Detrending Changes the Temporal Dynamics of a Semantic Fluency Task. Front Aging Neurosci (2016) 0.75
Long-term oral administration of hop flower extracts mitigates Alzheimer phenotypes in mice. PLoS One (2014) 0.75
Secrets of aging: What does a normally aging brain look like? F1000 Biol Rep (2011) 0.75
Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi. Brain Pathol (2017) 0.75
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. Lancet Neurol (2017) 0.75
The emerging role of alternative splicing in senescence and aging. Aging Cell (2017) 0.75
Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease. Neurobiol Aging (2017) 0.75
Alzheimer Disease: Scientific Breakthroughs and Translational Challenges. Mayo Clin Proc (2017) 0.75
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A (1993) 15.04
Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol (2009) 11.05
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging (1997) 10.81
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med (1996) 10.60
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology (1992) 9.30
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet (2008) 8.51
Mitochondria: dynamic organelles in disease, aging, and development. Cell (2006) 8.30
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol (2009) 7.50
Observations on the brains of demented old people. J Neurol Sci (1970) 6.99
Changing complexity in human behavior and physiology through aging and disease. Neurobiol Aging (2001) 6.83
Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res (1979) 6.68
Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry (2006) 6.68
Age, neuropathology, and dementia. N Engl J Med (2009) 6.36
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2009) 5.94
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging (2005) 5.84
Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem (2009) 5.76
Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol (2002) 5.69
The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol (2010) 5.59
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord (2007) 5.01
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes (2002) 4.97
The genetics of Alzheimer disease: back to the future. Neuron (2010) 4.91
Telomeres and aging. Physiol Rev (2008) 4.79
Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol (2007) 4.47
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank (2008) 4.13
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci (2009) 3.97
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Staging of Alzheimer-related cortical destruction. Eur Neurol (1993) 3.58
"Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology (2000) 3.57
Neocortical neuron number in humans: effect of sex and age. J Comp Neurol (1997) 3.49
Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology (2002) 3.40
Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology (2010) 3.35
The aging brain. Annu Rev Pathol (2008) 3.28
Caspase activation precedes and leads to tangles. Nature (2010) 3.24
The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol (2009) 3.13
Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci (2002) 3.11
Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol (2010) 3.08
The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord (2004) 2.97
Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet (2000) 2.97
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91
The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry (1998) 2.91
Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol (2009) 2.87
Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem (2011) 2.86
Genetic variation and neuroimaging measures in Alzheimer disease. Arch Neurol (2010) 2.76
Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol (2002) 2.68
Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging (1997) 2.66
Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol (2007) 2.66
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65
Increased risk of type 2 diabetes in Alzheimer disease. Diabetes (2004) 2.61
Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord (2002) 2.56
The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis (2009) 2.54
Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol (2005) 2.52
Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review. Histopathology (2005) 2.52
Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis (1996) 2.50
Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology (2006) 2.48
Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab (2004) 2.46
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Neurodegenerative basis of age-related cognitive decline. Neurology (2010) 2.41
The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol (2000) 2.35
Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology. Brain (2010) 2.33
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology (2003) 2.32
AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol (2005) 2.31
Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement (2011) 2.26
Abeta species removal after abeta42 immunization. J Neuropathol Exp Neurol (2006) 2.25
APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain (2006) 2.23
Correlation between scores for dementia and counts of 'senile plaques' in cerebral grey matter of elderly subjects. Nature (1966) 2.23
Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol (1994) 2.23
Reimagining Alzheimer's disease--an age-based hypothesis. J Neurosci (2010) 2.12
Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest (2000) 2.11
Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol (2010) 2.09
Relationship of vascular risk to the progression of Alzheimer disease. Neurology (2006) 2.08
Genetic modulation of senescent phenotypes in Homo sapiens. Cell (2005) 2.07
Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing. Brain (2010) 2.04
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology (2008) 2.01
Validation of anti-aging drugs by treating age-related diseases. Aging (Albany NY) (2009) 2.01
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology (1996) 2.00
Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's disease. Neurology (2000) 1.95
Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol (2008) 1.93
Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol (2010) 1.93
Aging and the human neocortex. Exp Gerontol (2003) 1.92
Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol (2006) 1.92
Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging (1995) 1.90
Comparison of 18F-FDG and PiB PET in cognitive impairment. J Nucl Med (2009) 1.90
Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology (2010) 1.88
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol (2008) 1.85
Biological aging is no longer an unsolved problem. Ann N Y Acad Sci (2007) 1.82
Overestimation of clinical diagnostic performance caused by low necropsy rates. Qual Saf Health Care (2005) 1.82
Molecular mechanisms of aging-associated inflammation. Cancer Lett (2005) 1.80
Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol (2009) 1.76
Health and function of participants in the Long Life Family Study: A comparison with other cohorts. Aging (Albany NY) (2011) 1.74
Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement (2011) 1.71
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet (2005) 10.11
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Neuropathologic substrate of mild cognitive impairment. Arch Neurol (2006) 6.26
Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol (2006) 6.20
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener (2007) 4.15
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (2014) 3.75
Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res (2003) 3.71
Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death. Cancer Cell (2007) 3.37
Tooth loss, dementia and neuropathology in the Nun study. J Am Dent Assoc (2007) 3.29
Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest (2005) 3.15
Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Cancer Res (2005) 2.98
TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol (2007) 2.97
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2005) 2.97
Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol (2007) 2.70
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65
Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg (2005) 2.53
Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc (2006) 2.48
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol (2006) 2.43
Predicting risk of malignancy in adnexal masses. Obstet Gynecol (2010) 2.31
Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A (2008) 2.29
Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci U S A (2002) 2.28
Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly. Neurobiol Aging (2006) 2.23
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19
Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16
Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol (2006) 2.13
Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol Dis (2009) 2.12
Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther (2010) 2.09
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem (2008) 2.04
Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury. J Neurotrauma (2005) 2.03
PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells. Cancer Biol Ther (2009) 1.97
Patterns of colorectal cancer incidence, risk factors, and screening in Kentucky. South Med J (2004) 1.94
Dissociation of automatic and strategic lexical-semantics: functional magnetic resonance imaging evidence for differing roles of multiple frontotemporal regions. J Neurosci (2006) 1.92
Retracted Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochem Biophys Res Commun (2008) 1.91
Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther (2006) 1.88
Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol (2008) 1.88
Selecting treatment for patients with malignant epidural spinal cord compression-does age matter?: results from a randomized clinical trial. Spine (Phila Pa 1976) (2009) 1.79
Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstet Gynecol (2013) 1.77
Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation. Gynecol Oncol (2003) 1.75
APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology (2009) 1.74
Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol (2009) 1.73
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts. Cancer Biol Ther (2011) 1.72
Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol (2011) 1.72
Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Dig Dis Sci (2007) 1.72
A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. J Neuroinflammation (2007) 1.70
Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. J Neuropathol Exp Neurol (2009) 1.66
Lifelong bilingualism maintains neural efficiency for cognitive control in aging. J Neurosci (2013) 1.62
Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment. Proc Natl Acad Sci U S A (2003) 1.62
Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer (2007) 1.61
The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy. Cancer (2009) 1.59
Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol (2010) 1.58
Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation. Cancer Res (2007) 1.58
Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A (2008) 1.57
Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J Neuroinflammation (2008) 1.57
Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases. Cancer Res (2006) 1.56
Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected]. Brain Res (2009) 1.53
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. J Neurochem (2011) 1.53
Retracted Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J Biol Chem (2009) 1.53
University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res (2012) 1.52